3-53675824-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001128840.3(CACNA1D):​c.1220+2698T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 152,018 control chromosomes in the GnomAD database, including 7,922 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 7922 hom., cov: 32)

Consequence

CACNA1D
NM_001128840.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.54

Publications

11 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001128840.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.1220+2008T>C
intron
N/ANP_000711.1Q01668-2
CACNA1D
NM_001128840.3
MANE Select
c.1220+2698T>C
intron
N/ANP_001122312.1Q01668-1
CACNA1D
NM_001128839.3
c.1220+2698T>C
intron
N/ANP_001122311.1Q01668-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.1220+2008T>C
intron
N/AENSP00000288139.3Q01668-2
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.1220+2698T>C
intron
N/AENSP00000288133.5Q01668-1
CACNA1D
ENST00000481478.2
TSL:1
c.1220+2698T>C
intron
N/AENSP00000418014.2H0Y879

Frequencies

GnomAD3 genomes
AF:
0.324
AC:
49289
AN:
151900
Hom.:
7911
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.336
Gnomad AMI
AF:
0.342
Gnomad AMR
AF:
0.324
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.275
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.323
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.325
AC:
49332
AN:
152018
Hom.:
7922
Cov.:
32
AF XY:
0.323
AC XY:
23990
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.336
AC:
13911
AN:
41454
American (AMR)
AF:
0.323
AC:
4941
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
1044
AN:
3468
East Asian (EAS)
AF:
0.276
AC:
1426
AN:
5174
South Asian (SAS)
AF:
0.220
AC:
1059
AN:
4820
European-Finnish (FIN)
AF:
0.306
AC:
3235
AN:
10572
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.333
AC:
22605
AN:
67944
Other (OTH)
AF:
0.327
AC:
687
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1718
3436
5155
6873
8591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.326
Hom.:
25837
Bravo
AF:
0.324
Asia WGS
AF:
0.255
AC:
889
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
12
DANN
Benign
0.69
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1460118; hg19: chr3-53709851; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.